Insperity, Inc. (NSP) Guidance & Earnings Results
On 2026-07-29 Insperity, Inc. lowered guidance: "Full-year 2026 average WSEEs guided to 305,000-307,000 (YoY -1.0% to -1.6%); adjusted EPS $1.88-$2.43; adjusted EBITDA…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NSPInsperity, Inc.Follow NSP — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- —
- Dividend yield
- 4.4%
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 29 Jul 26 | Lowered | Full-year 2026 average WSEEs guided to 305,000-307,000 (YoY -1.0% to -1.6%); adjusted EPS $1.88-$2.43; adjusted EBITDA $185M-$225M. · full year |
| 30 Apr 26 | Mixed | Q2 2026: average WSEEs 302,500-304,500 (y/y -2.1% to -1.5%), adjusted EPS $0.02-$0.50 (y/y -92% to +92%), adjusted EBITDA $18M-$46M (y/y -44% to +44%). FY2026: average WSEEs 303,000-307,000 (y/y -2.3% to -1.0%), adjusted EPS $1.60-$2.60 (y/y +55% to +152%), adjusted EBITDA $170M-$230M (y/y +30% to +76%). |
| 10 Feb 26 | Mixed | Q1 2026 adjusted EPS $1.03-1.50; FY2026 adjusted EPS $1.69-2.72; adjusted EBITDA $170-230M · full year |
| 3 Nov 25 | Lowered | Q4 adjusted EPS $(0.79)-$(0.16); full year adjusted EPS $0.84-$1.47 · full year |
| 1 Aug 25 | Lowered | FY25 adj EPS $1.81-$2.51 (down ~49-30% y/y); Q3 adj EPS $0.06-$0.49; FY25 adj EBITDA $170-$205M; Q3 adj EBITDA $24-$44M · full year |
Insperity, Inc. — questions
- What guidance did Insperity, Inc. give?
- On 2026-07-29: "Full-year 2026 average WSEEs guided to 305,000-307,000 (YoY -1.0% to -1.6%); adjusted EPS $1.88-$2.43; adjusted EBITDA $185M-$225M."
- When does Insperity, Inc. report earnings?
- Insperity, Inc.'s next earnings report is expected on 2026-10-29.
Every figure on this page comes from Insperity, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.